Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancer: A large single-institution experience.

被引：1
|
作者：
Mitchell, Melissa Pulfer
Abboud, Mirna
Crane, Christopher H.
Eng, Cathy
Chang, George J.
Rodriguez-Bigas, Miguel A.
Skibber, John Michael
You, Y. Nancy
Beddar, Sam
Krishnan, Sunil
Delclos, Marc E.
Das, Prajnan
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Methodist Hosp, 6535 Fannin, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.661
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
661
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience
    Salama, Joseph K.
    Mell, Loren K.
    Schomas, David A.
    Miller, Robert C.
    Devisetty, Kiran
    Jani, Ashesh B.
    Mundt, Arno J.
    Roeske, John C.
    Liauw, Stanley L.
    Chmura, Steven J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) : 4581 - 4586
  • [2] Intensity Modulated Radiation Therapy for Anal Canal Cancer: A Large Single Institution Experience
    White, E. C.
    Erickson, K. T.
    Rao, A.
    Lien, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S330 - S331
  • [3] Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Anal Cancer Outcomes and Toxicity
    Mitchell, Melissa P.
    Abboud, Mirna
    Eng, Cathy
    Beddar, A. Sam
    Krishnan, Sunil
    Delclos, Marc E.
    Crane, Christopher H.
    Das, Prajnan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (05): : 461 - 466
  • [4] Intensity-modulated radiation therapy combined with concurrent and adjuvant chemotherapy in anaplastic thyroid carcinoma: A single-institution study
    Bible, K. C.
    Molina, J. R.
    Kasperbauer, J. C.
    Lloyd, R. V.
    McIver, B.
    Morris, J. C., III
    Hay, I. D.
    Suman, V.
    Smallridge, R. C.
    Foote, R. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Pelvic insufficiency fracture (PIF) incidence in patients treated with intensity-modulated radiation therapy (IMRT) for gynaecological or anal cancer: single-institution experience and review of the literature
    Bazire, Louis
    Xu, Haoping
    Foy, Jean-Philippe
    Amessis, Malika
    Malhaire, Caroline
    Cao, Kim
    De La Rochefordiere, Anne
    Kirova, Youlia M.
    BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1073):
  • [6] Intensity-modulated radiotherapy treatment of anal cancer: single-institution outcomes
    Scott, E.
    Kar, A.
    Ariyaratne, H.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S582 - S582
  • [7] INTENSITY-MODULATED RADIOTHERAPY (IMRT) AND CONCURRENT CHEMOTHERAPY FOR ANAL AND PERIANAL CANCER: THE PRINCESS MARGARET HOSPITAL EXPERIENCE
    Han, K.
    Skliarenko, J.
    Craig, T.
    Le, L. W.
    Cummings, B. J.
    Bayley, A. J.
    Brierley, J. D.
    Cho, C.
    Dawson, L. A.
    Dinniwell, R.
    Kassam, Z.
    Ringash, J.
    Wong, R. K.
    Krzyzanowska, M. K.
    Mackay, H. J.
    Moore, M. J.
    Chen, E. X.
    Feld, R.
    Knox, J.
    Kim, J. J.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S15 - S15
  • [8] Intensity-modulated radiation therapy (IMRT) for advanced oropharyngeal carcinoma: The MSKCC experience.
    de Arruda, FF
    Zhung, J
    Narayana, A
    Wolden, S
    Pfister, DG
    Serrano, V
    Kraus, DH
    Shaha, A
    Shah, J
    Lee, NY
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 503S - 503S
  • [9] Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancers: Acute toxicity profile and avoidance of a treatment break
    Nordal, R. A.
    Wood, T. E.
    Posey, J. A., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Concurrent Chemotherapy and Intensity Modulated Radiation Therapy (IMRT) in the Treatment of Anal Cancer: A Retrospective Review From a Large Academic Center
    Call, Jason
    Haddock, Michael
    Quevedo, J. Fernando
    David, Larson
    Miller, Robert
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (02): : 199 - 199
12345